What are James C. Foster’s direct CRL share holdings after these gifts?

After the reported gifts and exempt transfers, Foster directly holds 126,596 shares of Charles River Laboratories common stock. Separate entries also show significant indirect holdings through trusts and GRATs, providing additional exposure beyond this disclosed direct share count in his own name.

How does Rule 16a-13 relate to these CRL share transfers?

Footnotes state the 153,361-share, 20,000-share, and certain 10,000-share movements are exempt transfers under Rule 16a-13. This covers shifts between Foster’s or his spouse’s direct holdings and revocable trusts they control, treating them as non-reportable changes in beneficial ownership for some purposes.

CRL director gifts 366,722 company shares

Charles River Laboratories director James C. Foster reported exempt, bona fide gifts and related trust transfers of 366,722 shares of common stock dated 2026-06-05.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Charles River Laboratories director James C. Foster reported exempt, bona fide gifts and related trust transfers of 366,722 shares of common stock dated 2026-06-05. The Form 4 shows these shares moving among his direct holdings, revocable trusts he controls, and trusts associated with his spouse, all at a stated price of $0.00 per share, indicating no sale proceeds. Following these transactions, Foster holds 106,596 shares directly and 155,611 shares indirectly through a trust, plus additional indirect positions of 20,000 shares in a 2026 GRAT, 10,780 shares in a 2025 GRAT, 5,423 shares in a 2024 GRAT, and 10,000 shares in a trust held by his spouse.

Insider Trade Summary

366,722 shares gifted

Gift 8 txns

Insider FOSTER JAMES C

Role Director

Type	Security	Shares	Price	Value
Gift	Common Stock	153,361	$0.00	$0.00
Gift	Common Stock	153,361	$0.00	$0.00
Gift	Common Stock	20,000	$0.00	$0.00
Gift	Common Stock	20,000	$0.00	$0.00
Gift	Common Stock	10,000	$0.00	$0.00
Gift	Common Stock	10,000	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 155,611 shares (Indirect, By Trust); Common Stock — 106,596 shares (Direct); Common Stock — 20,000 shares (Indirect, 2026 GRAT); Common Stock — 0 shares (Indirect, Held By Spouse); Common Stock — 10,000 shares (Indirect, By Trust Held By Spouse); Common Stock — 10,780 shares (Indirect, 2025 GRAT); Common Stock — 5,423 shares (Indirect, 2024 GRAT)

Footnotes (3)

F1. Reflects the exempt transfer pursuant to Rule 16a-13 of 153,361 shares held by the reporting person to a revocable trust controlled by the reporting person.
F2. Reflects the exempt transfer pursuant to Rule 16a-13 of 20,000 shares held by the reporting person to a revocable trust controlled by the reporting person.
F3. Reflects the exempt transfer pursuant to Rule 16a-13 of 10,000 shares held by the reporting person's spouse to a revocable trust controlled by the reporting person's spouse.

Key Figures

Total gifted or exempt transferred shares: 366,722 shares Direct holdings after transfers: 126,596 shares Trust holdings after transfers: 155,611 shares +4 more

7 metrics

Total gifted or exempt transferred shares 366,722 shares Bona fide gifts and exempt transfers on 2026-06-05

Direct holdings after transfers 126,596 shares Common stock held directly after 2026-06-05 transactions

Trust holdings after transfers 155,611 shares Common stock held indirectly "By Trust" after transfers

2026 GRAT holdings 20,000 shares Common stock held indirectly via 2026 GRAT

2025 GRAT holdings 10,780 shares Common stock held indirectly via 2025 GRAT

2024 GRAT holdings 5,423 shares Common stock held indirectly via 2024 GRAT

Spouse trust holdings 10,000 shares Common stock held indirectly by trust held by spouse

Key Terms

bona fide gift, Rule 16a-13, revocable trust, GRAT

4 terms

bona fide gift financial

"transaction_code_description": "Bona fide gift""

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

Rule 16a-13 regulatory

"Reflects the exempt transfer pursuant to Rule 16a-13 of 153,361 shares"

revocable trust financial

"to a revocable trust controlled by the reporting person"

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

GRAT financial

""nature_of_ownership": "2026 GRAT""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CRL director James C. Foster report in this Form 4?

James C. Foster reported exempt, bona fide gifts and trust transfers totaling 366,722 shares of Charles River Laboratories common stock. The shares moved among his direct holdings, revocable trusts he controls, and spouse-related trusts, with no sale price and no open-market transactions disclosed.

How many CRL shares did James C. Foster transfer as gifts?

The filing shows 366,722 CRL common shares treated as bona fide gifts or exempt transfers. Individual entries include 153,361-share and 20,000-share transfers to revocable trusts and 10,000-share transfers involving a spouse and a spouse-controlled trust, all at a reported price of $0.00 per share.

Were James C. Foster’s CRL transactions open-market sales or buys?

No open-market purchases or sales are reported. All coded transactions use “G” for bona fide gifts or exempt transfers under Rule 16a-13, with a stated price of $0.00 per share, indicating intra-family and trust-related movements rather than market trading activity in CRL stock.

What indirect CRL holdings through trusts does James C. Foster report?

Foster reports 155,611 CRL shares held by a trust, 20,000 shares in a 2026 GRAT, 10,780 shares in a 2025 GRAT, 5,423 shares in a 2024 GRAT, and 10,000 shares in a trust held by his spouse, all classified as indirect ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/08/2026 - 04:25 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FOSTER JAMES C

(Last)

(First)

(Middle)

C/O CHARLES RIVER LABORATORIES

251 BALLARDVALE STREET

(Street)

WILMINGTON

MASSACHUSETTS

01887

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. [ CRL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/05/2026		G		153,361⁽¹⁾	D	$0	126,596	D
Common Stock	06/05/2026		G		153,361⁽¹⁾	A	$0	155,611	I	By Trust
Common Stock	06/05/2026		G		20,000⁽²⁾	D	$0	106,596	D
Common Stock	06/05/2026		G		20,000⁽²⁾	A	$0	20,000	I	2026 GRAT
Common Stock	06/05/2026		G		10,000⁽³⁾	D	$0	0	I	Held By Spouse
Common Stock	06/05/2026		G		10,000⁽³⁾	A	$0	10,000	I	By Trust Held By Spouse
Common Stock								10,780	I	2025 GRAT
Common Stock								5,423	I	2024 GRAT

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects the exempt transfer pursuant to Rule 16a-13 of 153,361 shares held by the reporting person to a revocable trust controlled by the reporting person.

2. Reflects the exempt transfer pursuant to Rule 16a-13 of 20,000 shares held by the reporting person to a revocable trust controlled by the reporting person.

3. Reflects the exempt transfer pursuant to Rule 16a-13 of 10,000 shares held by the reporting person's spouse to a revocable trust controlled by the reporting person's spouse.

	/s/ James C. Foster	06/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR